The pharmaceutical company and a subsidiary will pay a total of $60 million to resolve accusations that it paid doctors in several countries to prescribe its drugs.

This post is filed under Business. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.